Company Filing History:
7 out of 2,405 
1 out of 40 
Years Active: 2013-2022
Title: Chaomin Li: A Prolific Inventor in Boston
Introduction:
Chaomin Li, a talented inventor based in Boston, Massachusetts, has made significant contributions to the field of pharmaceuticals with a total of 7 patents to his name. His groundbreaking work has been focused on developing compounds that target human phosphatidylinositol 3-kinase delta (PI3K-delta) for the treatment of various diseases such as inflammation, asthma, COPD, and cancer.
Latest Patents:
Chaomin Li's latest patents include novel purine inhibitors of human phosphatidylinositol 3-kinase delta. These compounds, outlined in formulas Ia, Ib, and I, serve as potent PI3K-delta inhibitors with promising implications for combating PI3K-delta-mediated ailments.
Career Highlights:
Throughout his career, Chaomin Li has been associated with reputable pharmaceutical companies such as Merck Sharp & Dohme Corporation and Merck Canada Inc.. His expertise and innovative approach have played a pivotal role in advancing the development of therapeutic agents targeting PI3K-delta.
Collaborations:
In his quest for scientific excellence, Chaomin Li has collaborated closely with esteemed colleagues such as Hua Zhou and Matthew Christopher. Together, they have fostered a dynamic research environment, leading to the successful implementation of novel drug candidates.
Conclusion:
Chaomin Li's relentless dedication to scientific innovation and his remarkable contributions to the pharmaceutical industry underscore his status as a pioneering inventor. His patents and collaborations stand as a testament to his invaluable impact on the field of medicine, offering new hope for patients battling PI3K-delta-related conditions.